Skip to main content
OpenTrials

Clinical trial condition

Advanced or Metastatic Solid Tumors

Explore clinical trials studying Advanced or Metastatic Solid Tumors. Study availability and eligibility vary by location and protocol.

53 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Advanced or Metastatic Solid Tumors trial results

Completed

A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors

NCT00907205

Conditions
Advanced or Metastatic Solid Tumors, Cancer, Neoplasms, +1 more
Locations
  • Scottsdale Clinical Research Institute Scottsdale, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
View Trial Details
Terminated

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View all 17 locations
View Trial Details

Related conditions